Avicanna Announces Changes to its Board of Directors
January 04, 2022 07:30 ET
|
Avicanna Inc.
TORONTO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing...
Avicanna Completes First Commercial Export of CBG Into the European Union
December 24, 2021 07:30 ET
|
Avicanna Inc.
First commercial export of Cannabigerol (CBG), a rare cannabinoid, into Czech Republic This export represents the 14th international market entrance for Avicanna products TORONTO, Dec. 24, 2021 ...
Avicanna Launches its Clinically Backed CBD Derma-cosmetics Brand, Pura H&W, in the United States in Partnership with Red White and Bloom
December 22, 2021 07:30 ET
|
Avicanna Inc.
The THC-Free, CBD derma-cosmetic brand is the first known CBD skincare line to be clinically tested and commercialized across four international markets The initial launch of Pura H&W will...
Avicanna and Harrington Wellness launch re+PLAY™ branded CBD topicals products in Canada
December 20, 2021 07:30 ET
|
Avicanna Inc.
re+PLAY is a sports performance and recovery-focused brand founded by NBA veteran Al Harrington with and evidence-based CBD formulations developed in partnership with Avicanna Products will be...
Avicanna to Participate in the Lytham Partners Winter 2021 Investor Conference
December 10, 2021 07:30 ET
|
Avicanna Inc.
TORONTO, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing,...
Avicanna Files a Patent to Protect its Advanced Oral Cannabinoid Platform and its Applications for Neurological Diseases
December 06, 2021 07:30 ET
|
Avicanna Inc.
Proprietary formulations include a range of liquids, capsules, powders, and controlled release tablets utilizing Avicanna’s self-emulsifying drug delivery systems (SEDDS) technology The advanced...
Avicanna Enters into an Intellectual Property Licensing and Distribution Agreement with Established Pharmaceutical Company in Argentina
November 30, 2021 07:30 ET
|
Avicanna Inc.
TORONTO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing,...
Avicanna Expands its Medical Cannabis Brand RHO Phyto into the Caribbean Region with Initial Export to Barbados
November 25, 2021 07:30 ET
|
Avicanna Inc.
Starting with 3 SKUs, the advanced medical cannabis formulary will be available for the medical community and patients through prescriptionDistribution partnership with Bryden Stokes Limited includes...
Avicanna Announces Filing of Interim Financial Statements for the Three-Month Period Ending September 30, 2021, Demonstrating Progressive Commercialization Results
November 12, 2021 07:30 ET
|
Avicanna Inc.
Record gross revenue of $1,007,033 through steady growth and progression of global commercializationDelivered a record number (27,041) of units of cannabis 2.0 products globally, an increase of 61%...
Avicanna Announces Resignation of Director
November 11, 2021 19:30 ET
|
Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...